IT1298731B1 - PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN

Info

Publication number
IT1298731B1
IT1298731B1 IT98MI000510A ITMI980510A IT1298731B1 IT 1298731 B1 IT1298731 B1 IT 1298731B1 IT 98MI000510 A IT98MI000510 A IT 98MI000510A IT MI980510 A ITMI980510 A IT MI980510A IT 1298731 B1 IT1298731 B1 IT 1298731B1
Authority
IT
Italy
Prior art keywords
melatonin
pharmaceutical compositions
compositions containing
containing complex
complex inclusion
Prior art date
Application number
IT98MI000510A
Other languages
Italian (it)
Inventor
Giancarlo Santus
Roberto Golzi
Giampiero Besana
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Priority to IT98MI000510A priority Critical patent/IT1298731B1/en
Priority to AU34100/99A priority patent/AU3410099A/en
Priority to PCT/EP1999/001539 priority patent/WO1999047175A1/en
Publication of ITMI980510A1 publication Critical patent/ITMI980510A1/en
Application granted granted Critical
Publication of IT1298731B1 publication Critical patent/IT1298731B1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT98MI000510A 1998-03-13 1998-03-13 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN IT1298731B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT98MI000510A IT1298731B1 (en) 1998-03-13 1998-03-13 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN
AU34100/99A AU3410099A (en) 1998-03-13 1999-03-10 Pharmaceutical compositions containing melatonin inclusion complexes
PCT/EP1999/001539 WO1999047175A1 (en) 1998-03-13 1999-03-10 Pharmaceutical compositions containing melatonin inclusion complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI000510A IT1298731B1 (en) 1998-03-13 1998-03-13 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN

Publications (2)

Publication Number Publication Date
ITMI980510A1 ITMI980510A1 (en) 1999-09-13
IT1298731B1 true IT1298731B1 (en) 2000-02-02

Family

ID=11379301

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI000510A IT1298731B1 (en) 1998-03-13 1998-03-13 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN

Country Status (3)

Country Link
AU (1) AU3410099A (en)
IT (1) IT1298731B1 (en)
WO (1) WO1999047175A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5600058B2 (en) 2007-04-11 2014-10-01 ファーマシューティカル プロダクションズ, インコーポレイテッド Melatonin tablets, preparations and methods of use
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
ITMI20112042A1 (en) * 2011-11-10 2013-05-11 Eratech S R L POWDER TO RECONSTITUTE BEFORE INCLUDING MELATONIN AND INJECTABLE PREPARATION OBTAINABLE FROM SUCH POWDER.
WO2016142341A1 (en) * 2015-03-06 2016-09-15 Repoceuticals Aps Melatonin for preventing and treating radiation vaginitis and proctitis
NL2015272B1 (en) 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
ITUB20156299A1 (en) * 2015-12-03 2017-06-03 S B M S R L Product comprising collagen and at least one micronized amorphous drug, a process for its preparation and related uses in the medical field.
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited Pharmaceutical composition of melatonin
EP3705117A1 (en) 2019-03-05 2020-09-09 Tradichem Industrial Services, S.L. Melatonin having improved water solubility, its preparation and uses thereof
AU2020339867A1 (en) * 2019-08-30 2022-04-14 Vijayendrakumar Virendrakumarji Redasani Liquid pharmaceutical compositions of melatonin for oral and parenteral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU730216B2 (en) * 1996-09-01 2001-03-01 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
EP0867181A1 (en) * 1997-03-26 1998-09-30 Franciscus Wilhelmus Henricus Maria Merkus Nasal melatonin composition
CN1112184C (en) * 1998-04-13 2003-06-25 广州市美乐健生物技术有限公司 Melatonin slow-releasing agent and its production process

Also Published As

Publication number Publication date
ITMI980510A1 (en) 1999-09-13
WO1999047175A1 (en) 1999-09-23
AU3410099A (en) 1999-10-11

Similar Documents

Publication Publication Date Title
DE69924999D1 (en) LIPASEHEMMER CONTAINING PHARMACEUTICAL COMPOSITIONS
ID27415A (en) PHARMACEUTICAL COMPOSITION
EA199900373A3 (en) PHARMACEUTICAL COMPOSITIONS
NO20005913L (en) Medicinal Composition
NO20015175L (en) Pharmaceutical composition
DE69832516D1 (en) ISOFLAVON CONTAINING COMPOSITIONS
NO995925D0 (en) Pharmaceutical compositions comprising cyclodextrins
DE69836106D1 (en) Stanolester containing compositions
DK1052974T3 (en) Pharmaceutical composition containing epothilone
DE69900634T2 (en) SHAMPOO COMPOSITIONS
PT1242087E (en) PHARMACEUTICAL COMPOSITIONS
ID29262A (en) PHARMACEUTICAL COMPOSITION
DE69900561D1 (en) Pharmaceutical compositions containing mupirocin
ITMI982222A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENERPHINE
ID27201A (en) PHARMACEUTICAL COMPOSITION
ATE357237T1 (en) FORMULATIONS CONTAINING CEFUROXIM-AXETIL
DE69943245D1 (en) GAS-CREATING COMPOSITION
PT1239832E (en) PHARMACEUTICAL COMPOSITIONS
IT1298731B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN
PT969815E (en) PHARMACEUTICAL COMPOSITIONS
PT1227817E (en) AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING
EE9900206A (en) Pharmaceutical compositions containing N-sulfonylindoline derivatives
EE200000330A (en) Pharmaceutical compositions
FI4488U1 (en) Pharmaceutical composition
PT986537E (en) NEW HETERONETHYLENE COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
0001 Granted